172 related articles for article (PubMed ID: 4349762)
21. Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in human lymphoblastoid cell lines by means of an 125-I-IgG-binding assay.
Brown TD; Ernberg I; Lamon EW; Klein G
Int J Cancer; 1974 Jun; 13(6):785-94. PubMed ID: 4368574
[No Abstract] [Full Text] [Related]
22. Antibodies in human sera to soluble and viral antigens found in Burkitt lymphoma and other lymphoblastoid cell lines.
Vonka V; Benyesh-Melnick M; McCombs RM
J Natl Cancer Inst; 1970 Apr; 44(4):865-72. PubMed ID: 11515054
[No Abstract] [Full Text] [Related]
23. Effect of hydrocortisone on cell viability, Epstein-Barr virus genome expression, and interferon synthesis in human lymphoblastoid cell lines.
Joncas J; Boucher J; Boudreault A; Granger-Julien M
Cancer Res; 1973 Sep; 33(9):2142-8. PubMed ID: 4353485
[No Abstract] [Full Text] [Related]
24. A practical and quantitative microtest for determination of neutralizing antibodies against Epstein-Barr virus.
Rocchi G; Hewetson JF
J Gen Virol; 1973 Mar; 18(3):385-91. PubMed ID: 4348798
[No Abstract] [Full Text] [Related]
25. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine.
Yamamoto N; Mueller-Lantzsch N; zur Hausen H
Int J Cancer; 1980 Apr; 25(4):439-43. PubMed ID: 6246007
[TBL] [Abstract][Full Text] [Related]
26. Control of interferon, migration inhibition factor, and expression of virus capsid antigens in Burkitt's lymphoma-derived cell lines: role of L-arginine.
Archer DL; Young BG
Infect Immun; 1974 Apr; 9(4):684-9. PubMed ID: 4362772
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo studies with Epstein-Barr virus (EBV). A review.
Dunkel VC
Ann Clin Lab Sci; 1973; 3(6):424-8. PubMed ID: 4356929
[No Abstract] [Full Text] [Related]
28. Evaluation of delayed hypersensitivity reactions to lymphoid cell lines and antibodies to Epstein-Barr virus.
Levine PH; Ho JH; Nkrumah F; Andrese AP
IARC Sci Publ (1971); 1978; (24 Pt 2):893-8. PubMed ID: 221411
[No Abstract] [Full Text] [Related]
29. Comparison of antigens from human and chimpanzee herpes-type virus-infected hemic cell lines.
Stevens DA; Pry TW; Blackham EA; Manaker RA
Proc Soc Exp Biol Med; 1970 Feb; 133(2):678-83. PubMed ID: 4313153
[No Abstract] [Full Text] [Related]
30. Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens.
Pearson GR; Orr TW
J Natl Cancer Inst; 1976 Mar; 56(3):485-8. PubMed ID: 176393
[TBL] [Abstract][Full Text] [Related]
31. Studies on the relation of membrane immunofluorescence to Epstein-Barr virus infection.
Dunkel VC; Zeigel RF
J Natl Cancer Inst; 1970 Jan; 44(1):133-44. PubMed ID: 11515024
[No Abstract] [Full Text] [Related]
32. Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.
Klein G; Lindahl T; Jondal M; Leibold W; Menézes J; Nilsson K; Sundström C
Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3283-6. PubMed ID: 4369887
[TBL] [Abstract][Full Text] [Related]
33. Immune complexes associated with neoplasia: presence of Epstein-Barr virus antigen-antibody complexes in Burkitt's lymphoma.
Oldstone MB; Theofilopoulos AN; Gunvén P; Klein G
Intervirology; 1974; 4(5):292-302. PubMed ID: 4377147
[No Abstract] [Full Text] [Related]
34. Synthesis of virus-capsid antigen (VCA) enhanced by ultraviolet irradiation of a lymphoblastoid cell line carrying Epstein-Barr virus.
Lai PK; Mackay-Scollay EM; Alpers MP
J Gen Virol; 1973 Oct; 21():135-43. PubMed ID: 4361743
[No Abstract] [Full Text] [Related]
35. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus.
Svedmyr A; Demissie A; Klein G; Clifford P
J Natl Cancer Inst; 1970 Mar; 44(3):595-610. PubMed ID: 11515428
[No Abstract] [Full Text] [Related]
36. Activation of Epstein-Barr virus in hybrid cells.
Tsang KY; Hann WD
J Natl Cancer Inst; 1977 May; 58(5):1295-301. PubMed ID: 192898
[TBL] [Abstract][Full Text] [Related]
37. [Superinfection of human lymphoblastoid cells with EB virus (author's transl)].
Vlcková I; Vonka V
Cesk Epidemiol Mikrobiol Imunol; 1975 Jan; 24(1):3-8. PubMed ID: 165904
[No Abstract] [Full Text] [Related]
38. Early events in transformation of human cord leukobytes by Epstain-Barr virus: induction of DNA synthesis, mitosis and the virus-associated nuclear antigen synthesis.
Aya T; Osato T
Int J Cancer; 1974 Sep; 14(3):341-7. PubMed ID: 4376517
[No Abstract] [Full Text] [Related]
39. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
Gavioli R; De Campos-Lima PO; Kurilla MG; Kieff E; Klein G; Masucci MG
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5862-6. PubMed ID: 1321426
[TBL] [Abstract][Full Text] [Related]
40. Difference in heat stability of antigens associated with Epstein-Barr virus, demonstrated by immunodiffusion.
Demissie A
J Natl Cancer Inst; 1973 Sep; 51(3):751-60. PubMed ID: 4355217
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
